JP2023515806A5 - - Google Patents
Info
- Publication number
- JP2023515806A5 JP2023515806A5 JP2022550673A JP2022550673A JP2023515806A5 JP 2023515806 A5 JP2023515806 A5 JP 2023515806A5 JP 2022550673 A JP2022550673 A JP 2022550673A JP 2022550673 A JP2022550673 A JP 2022550673A JP 2023515806 A5 JP2023515806 A5 JP 2023515806A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- arginine
- composition
- genetically modified
- item
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2026005807A JP2026063215A (ja) | 2020-02-21 | 2026-01-16 | 免疫細胞においてアルギニン濃度をモジュレートするための方法および組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062979805P | 2020-02-21 | 2020-02-21 | |
| US62/979,805 | 2020-02-21 | ||
| PCT/CN2021/077002 WO2021164753A1 (en) | 2020-02-21 | 2021-02-20 | Methods and compositions for modulating arginine levels in immune cells |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026005807A Division JP2026063215A (ja) | 2020-02-21 | 2026-01-16 | 免疫細胞においてアルギニン濃度をモジュレートするための方法および組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023515806A JP2023515806A (ja) | 2023-04-14 |
| JP2023515806A5 true JP2023515806A5 (https=) | 2024-02-29 |
Family
ID=77390457
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022550673A Pending JP2023515806A (ja) | 2020-02-21 | 2021-02-20 | 免疫細胞においてアルギニン濃度をモジュレートするための方法および組成物 |
| JP2026005807A Pending JP2026063215A (ja) | 2020-02-21 | 2026-01-16 | 免疫細胞においてアルギニン濃度をモジュレートするための方法および組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026005807A Pending JP2026063215A (ja) | 2020-02-21 | 2026-01-16 | 免疫細胞においてアルギニン濃度をモジュレートするための方法および組成物 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20230265386A1 (https=) |
| EP (1) | EP4107254A4 (https=) |
| JP (2) | JP2023515806A (https=) |
| KR (1) | KR20220157396A (https=) |
| CN (1) | CN115427553A (https=) |
| AR (1) | AR121392A1 (https=) |
| AU (1) | AU2021223138A1 (https=) |
| BR (1) | BR112022016571A2 (https=) |
| CA (1) | CA3171901A1 (https=) |
| IL (1) | IL295606A (https=) |
| MX (1) | MX2022010280A (https=) |
| TW (1) | TW202144569A (https=) |
| WO (1) | WO2021164753A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202018554D0 (en) * | 2020-11-25 | 2021-01-06 | Cancer Research Tech Ltd | Nucleic acid constructs and cells |
| CN114788870B (zh) * | 2022-04-29 | 2023-06-06 | 浙江大学 | 靶向免疫细胞长效补充精氨酸并中和酸环境的组合物及应用 |
| WO2026063691A1 (ko) * | 2024-09-20 | 2026-03-26 | 삼성바이오에피스 주식회사 | 아르기니노숙시네이트 합성효소를 암호화하는 코돈-최적화된 폴리뉴클레오티드 및 이를 포함하는 rAAV 생산용 플라스미드 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013151665A2 (en) * | 2012-04-02 | 2013-10-10 | modeRNA Therapeutics | Modified polynucleotides for the production of proteins associated with human disease |
| JP7623784B2 (ja) * | 2016-10-13 | 2025-01-29 | ジュノー セラピューティクス インコーポレイテッド | トリプトファン代謝経路調節剤を含む免疫療法の方法および組成物 |
| GB201701332D0 (en) * | 2017-01-26 | 2017-03-15 | Tc Biopharm Ltd | Immune cells with modified metabolism and their use thereof |
| GB201721833D0 (en) * | 2017-12-22 | 2018-02-07 | Cancer Research Tech Ltd | Fusion proteins |
-
2021
- 2021-02-20 WO PCT/CN2021/077002 patent/WO2021164753A1/en not_active Ceased
- 2021-02-20 JP JP2022550673A patent/JP2023515806A/ja active Pending
- 2021-02-20 EP EP21757810.3A patent/EP4107254A4/en active Pending
- 2021-02-20 CN CN202180026648.4A patent/CN115427553A/zh active Pending
- 2021-02-20 CA CA3171901A patent/CA3171901A1/en active Pending
- 2021-02-20 US US17/800,958 patent/US20230265386A1/en active Pending
- 2021-02-20 MX MX2022010280A patent/MX2022010280A/es unknown
- 2021-02-20 AU AU2021223138A patent/AU2021223138A1/en active Pending
- 2021-02-20 KR KR1020227032553A patent/KR20220157396A/ko active Pending
- 2021-02-20 IL IL295606A patent/IL295606A/en unknown
- 2021-02-20 BR BR112022016571A patent/BR112022016571A2/pt unknown
- 2021-02-20 TW TW110105930A patent/TW202144569A/zh unknown
- 2021-02-22 AR ARP210100448A patent/AR121392A1/es unknown
-
2026
- 2026-01-16 JP JP2026005807A patent/JP2026063215A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021523110A (ja) | 遺伝子発現のためのナノ粒子及びその使用 | |
| TWI334442B (en) | Process for producing cytotoxic lymphocyte | |
| EP0259212B1 (fr) | Expression d'un antigène spécifique de tumeur par un virus vecteur recombinant et utilisation de celui-ci pour le traitement préventif ou curatif de la tumeur correspondante | |
| JP2023515806A5 (https=) | ||
| JP2010516290A5 (https=) | ||
| HU230364B1 (hu) | Simian adenovírus nukleinsav és aminosav-szekvencia, azt tartalmazó vektorok, és eljárások annak alkalmazására | |
| JP2026063215A5 (https=) | ||
| CN107708725A (zh) | 用于引发免疫应答的剂和组合物 | |
| CN113481167B (zh) | 一种免疫细胞外泌体及其应用 | |
| US20210369824A1 (en) | Methods and materials for treating cancer | |
| CN119061030A (zh) | 表达SARS-CoV-2受体结合域的多核苷酸、蛋白、病毒载体及制备方法、疫苗制剂及制备方法及应用 | |
| FR2757169A1 (fr) | Proteine de fusion comportant tout ou partie de la proteine pp65 de cmv humain, utile notamment dans la preparation d'un vaccin | |
| CN100467063C (zh) | 一类免疫佐剂及其在抗病毒疫苗或药物制备中的应用 | |
| US8142791B2 (en) | Multi-modal cancer therapy using viral hitch-hiking | |
| JP2001524934A (ja) | 遺伝子治療ウイルスベクターの投与に対して哺乳類罹患動物を寛容化する方法 | |
| Haas et al. | Bispecific antibodies increase T-cell stimulatory capacity in vitro of human autologous virus-modified tumor vaccine. | |
| US20240325510A1 (en) | Novel anti-cancer vaccine composition and a method of vaccination using the same | |
| CN102898508B (zh) | 封闭TGF-β受体或IL-10受体的多肽、其药物组合物及其用途 | |
| JP2024540276A (ja) | がんを治療するための方法及び材料 | |
| CN114591401A (zh) | SARS-CoV-2编码蛋白来源的T细胞表位多肽HLVDFQVTI及其应用 | |
| US20250228925A1 (en) | Methods and related aspects for increasing antigenic insertion sites on a recombinant immune complex platform | |
| WO2022230971A1 (ja) | コロナウイルスに対する免疫応答を誘発する人工アジュバントベクター細胞、および当該細胞を含む医薬組成物、並びにそれらの使用 | |
| KR20260033046A (ko) | 전신성 홍반성 루푸스의 치료를 위한 조성물 및 방법 | |
| CN117645974A (zh) | 新冠病毒m蛋白限制性表位多肽致敏的树突状细胞及其应用 | |
| Yan et al. | COVID-19: The vaccine development strategies |